510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K031296Substantially Equivalent

Liqui-Heme Glyco A1c Assay

Biodiagnostic Intl, Brea CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K031296 is the FDA 510(k) clearance record for LIQUI-HEME GLYCO A1C ASSAY, a class II device, cleared for Biodiagnostic Intl on under FDA product code LCP (Assay, Glycosylated Hemoglobin). FDA records list 11 510(k) clearances for Biodiagnostic Intl, from to . As of , FDA records show no recalls naming K031296.

Clearance record

Decision date
Received
(541 days to decision)
Product code
LCP Assay, Glycosylated Hemoglobin
Regulation
21 CFR 864.7470
Device class
Class II
Review panel
Hematology
Applicant
Biodiagnostic Intl 615 N. Berry St., Brea CA
510(k) summary
Statement
Third party review
No

Clearances, product code LCP

Trailing 12 months

FDA records hold no clearances under product code LCP in the trailing twelve months.

FDA records show no clearances under product code LCP in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LCP, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260